• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP TA; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP TA; STAPLE, IMPLANTABLE Back to Search Results
Model Number TA30V3S
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 02/18/2026
Type of Reportable Event Malfunction
Event or Problem Description
Two ta staplers with dst series technology did not function as expected.1.Lot # p5j1221, exp 08/31/2030.2.Lot # p5e1152, exp 04/30/2030.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TA
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
COVIDIEN LP
60 middletown ave
north haven CT 06473
MDR Report Key24828325
Report Number24828325
Device Sequence Number21440057
Product Code GDW
UDI-Device Identifier10884521043145
UDI-Public(01)10884521043145
Combination Product (Y/N)N
Initial Reporter StateTN
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 04/07/2026
Report Date (Section F) 04/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberTA30V3S
Device Lot NumberP5J1221, P5E1152
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Event Location Hospital
Date Report to Manufacturer04/09/2026
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date04/09/2026
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age53 YR
Patient SexMale
Patient Weight86 KG
Date Report Sent to FDA04/07/2026
-
-